 Janine Oliver
Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pelvic Organ Prolapse | 2 | 2017 | 41 | 1.180 |
Why?
| | Robotic Surgical Procedures | 2 | 2019 | 89 | 0.700 |
Why?
| | Urinary Incontinence, Stress | 1 | 2017 | 14 | 0.610 |
Why?
| | Nitric Oxide Synthase Type III | 2 | 2018 | 198 | 0.610 |
Why?
| | Fascia | 1 | 2017 | 17 | 0.610 |
Why?
| | Urinary Bladder Neck Obstruction | 1 | 2017 | 21 | 0.600 |
Why?
| | Surgical Mesh | 1 | 2017 | 41 | 0.590 |
Why?
| | Urethra | 1 | 2017 | 58 | 0.590 |
Why?
| | Urologic Surgical Procedures | 1 | 2017 | 94 | 0.560 |
Why?
| | Postoperative Complications | 2 | 2017 | 2235 | 0.560 |
Why?
| | Device Removal | 1 | 2017 | 127 | 0.550 |
Why?
| | Clitoris | 1 | 2014 | 9 | 0.500 |
Why?
| | Osteoprotegerin | 1 | 2013 | 23 | 0.460 |
Why?
| | Lower Urinary Tract Symptoms | 1 | 2013 | 47 | 0.420 |
Why?
| | Nitric Oxide | 1 | 2014 | 892 | 0.330 |
Why?
| | Melanoma | 2 | 2013 | 664 | 0.330 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2013 | 1167 | 0.320 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1171 | 0.310 |
Why?
| | Laparoscopy | 3 | 2019 | 417 | 0.310 |
Why?
| | Operative Time | 2 | 2017 | 114 | 0.300 |
Why?
| | Aldehyde Oxidoreductases | 2 | 2018 | 32 | 0.290 |
Why?
| | Stress, Psychological | 1 | 2013 | 972 | 0.260 |
Why?
| | Mental Disorders | 1 | 2013 | 939 | 0.250 |
Why?
| | Ureter | 2 | 2016 | 32 | 0.240 |
Why?
| | Gynecologic Surgical Procedures | 2 | 2019 | 49 | 0.200 |
Why?
| | Obesity | 1 | 2013 | 2746 | 0.180 |
Why?
| | Fascia Lata | 1 | 2019 | 5 | 0.170 |
Why?
| | Uterine Prolapse | 1 | 2019 | 14 | 0.170 |
Why?
| | Penile Erection | 1 | 2018 | 6 | 0.170 |
Why?
| | Erectile Dysfunction | 1 | 2018 | 37 | 0.160 |
Why?
| | Urinary Catheterization | 1 | 2017 | 24 | 0.150 |
Why?
| | Vagina | 1 | 2019 | 148 | 0.150 |
Why?
| | Phenazopyridine | 1 | 2016 | 1 | 0.150 |
Why?
| | Fluorescein | 1 | 2016 | 27 | 0.140 |
Why?
| | Surgical Flaps | 1 | 2017 | 118 | 0.140 |
Why?
| | Treatment Outcome | 4 | 2019 | 9342 | 0.140 |
Why?
| | Intraoperative Complications | 1 | 2016 | 132 | 0.130 |
Why?
| | Fluorescent Dyes | 1 | 2016 | 316 | 0.130 |
Why?
| | Soluble Guanylyl Cyclase | 1 | 2014 | 15 | 0.120 |
Why?
| | Female | 8 | 2019 | 61565 | 0.120 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2014 | 22 | 0.120 |
Why?
| | Caveolin 1 | 1 | 2014 | 23 | 0.120 |
Why?
| | Guanylate Cyclase | 1 | 2014 | 36 | 0.120 |
Why?
| | HSP90 Heat-Shock Proteins | 1 | 2014 | 45 | 0.120 |
Why?
| | Endothelium | 1 | 2014 | 120 | 0.120 |
Why?
| | Muscle, Smooth | 1 | 2014 | 157 | 0.120 |
Why?
| | Osteoclasts | 1 | 2013 | 36 | 0.110 |
Why?
| | Retrospective Studies | 4 | 2019 | 12978 | 0.110 |
Why?
| | Missouri | 1 | 2013 | 63 | 0.110 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 195 | 0.110 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2014 | 341 | 0.110 |
Why?
| | Endothelium, Vascular | 2 | 2018 | 907 | 0.100 |
Why?
| | Humans | 10 | 2019 | 118974 | 0.100 |
Why?
| | Vesico-Ureteral Reflux | 1 | 2011 | 21 | 0.100 |
Why?
| | Replantation | 1 | 2011 | 29 | 0.100 |
Why?
| | Neoplasm Metastasis | 1 | 2013 | 544 | 0.100 |
Why?
| | Middle Aged | 4 | 2019 | 27617 | 0.090 |
Why?
| | Robotics | 1 | 2011 | 83 | 0.090 |
Why?
| | Phosphorylation | 1 | 2014 | 1633 | 0.090 |
Why?
| | Cell Membrane | 1 | 2013 | 710 | 0.090 |
Why?
| | Immunotherapy | 1 | 2013 | 493 | 0.080 |
Why?
| | Cell Line, Tumor | 2 | 2013 | 2851 | 0.080 |
Why?
| | Comorbidity | 1 | 2013 | 1527 | 0.080 |
Why?
| | Adult | 3 | 2017 | 31512 | 0.070 |
Why?
| | Quality of Life | 1 | 2017 | 2366 | 0.070 |
Why?
| | Incidence | 1 | 2013 | 2424 | 0.070 |
Why?
| | HLA-A Antigens | 1 | 2006 | 50 | 0.070 |
Why?
| | beta 2-Microglobulin | 1 | 2006 | 47 | 0.070 |
Why?
| | Genes, MHC Class I | 1 | 2006 | 33 | 0.070 |
Why?
| | Body Mass Index | 1 | 2013 | 2092 | 0.060 |
Why?
| | Cytokines | 1 | 2013 | 1900 | 0.060 |
Why?
| | Antigen Presentation | 1 | 2006 | 194 | 0.060 |
Why?
| | Prognosis | 1 | 2013 | 3443 | 0.060 |
Why?
| | Phenotype | 1 | 2013 | 3003 | 0.060 |
Why?
| | Aged | 3 | 2019 | 19657 | 0.060 |
Why?
| | Mice, Inbred C57BL | 1 | 2014 | 4908 | 0.060 |
Why?
| | Follow-Up Studies | 1 | 2013 | 4596 | 0.060 |
Why?
| | Apoptosis | 1 | 2013 | 2484 | 0.060 |
Why?
| | Time Factors | 1 | 2013 | 6412 | 0.050 |
Why?
| | Prospective Studies | 1 | 2013 | 6471 | 0.050 |
Why?
| | Surveys and Questionnaires | 1 | 2013 | 4708 | 0.050 |
Why?
| | Signal Transduction | 1 | 2013 | 4709 | 0.040 |
Why?
| | Autografts | 1 | 2019 | 49 | 0.040 |
Why?
| | Penis | 1 | 2018 | 37 | 0.040 |
Why?
| | Sacrum | 1 | 2019 | 67 | 0.040 |
Why?
| | Urinary Catheters | 1 | 2016 | 8 | 0.040 |
Why?
| | Cystoscopy | 1 | 2016 | 16 | 0.040 |
Why?
| | Pelvic Floor | 1 | 2016 | 24 | 0.040 |
Why?
| | Animals | 2 | 2018 | 33381 | 0.040 |
Why?
| | Child | 2 | 2013 | 19129 | 0.040 |
Why?
| | Iatrogenic Disease | 1 | 2016 | 49 | 0.040 |
Why?
| | Adolescent | 1 | 2013 | 18480 | 0.030 |
Why?
| | Male | 3 | 2018 | 57801 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2018 | 2680 | 0.030 |
Why?
| | Regression Analysis | 1 | 2011 | 983 | 0.020 |
Why?
| | Ultrasonography | 1 | 2011 | 716 | 0.020 |
Why?
| | Length of Stay | 1 | 2011 | 1032 | 0.020 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2006 | 204 | 0.020 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2006 | 158 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2006 | 276 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2016 | 6561 | 0.020 |
Why?
| | Down-Regulation | 1 | 2006 | 627 | 0.010 |
Why?
| | Base Sequence | 1 | 2006 | 2159 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2006 | 2071 | 0.010 |
Why?
| | Mice | 1 | 2018 | 15520 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2006 | 2871 | 0.010 |
Why?
| | Models, Molecular | 1 | 2006 | 1435 | 0.010 |
Why?
| | Infant | 1 | 2011 | 8293 | 0.010 |
Why?
| | Child, Preschool | 1 | 2011 | 9491 | 0.010 |
Why?
|
|
Oliver's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|